Category: Medical Leadership

JeanMarie Guenot Is Leading The Fight Against Cancer

 

The Fight Against Cancer

JeanMarie Guenot is leading the fight against the current cancer epidemic. Cancer is one of the leading causes of deaths and treatment options available today simply aren’t able to do much about the prognosis of most cases. Guenot is changing all of this with her work at Amphivena Therapeutics. Here she is helping to advance our understanding of blood cancer and create better treatments for blood cancer. Recently Amphivena announced an entirely new line of blood cancer treatments.

Where Everything Goes From Here

Blood cancer is fairly unique among cancers in that it does not result in obvious masses that doctors can simply target and take out. It is the result of excessive cell growth and the resulting symptoms. JeanMarie Guenot’s approach to blood cancer changes everything by going after blood cancer in a way that works with the body’s immune system and encourages the body to fight back. As a result the patients suffer fewer symptoms while experiencing a superior level of treatment.

 

 

The Impact Of Amphivena Therapeutics

Amphivena Therapeutics has introduced a class of antibody therapy drugs into the cancer treatment market. These drugs offer a way to treat blood cancer using the body’s own immune system without any of the dangers commonly seen in chemotherapy. Traditional chemotherapy often destroys the immune system of the patient in hopes of destroying the cancer along with it. This results in many patients suffering from issues ranging from baldness to opportunistic infections. None of this is a concern with Amphivena’s drugs and that is attracting attention. Investors around the world are interested in inveisting in this company.

 

 

About JeanMarie Guenot

JeanMarie Guenot is a prominent researcher and entrepreneur with a focus on cancer. She has spent much of her life developing and promoting new treatments for cancer. She struck gold when she developed innovative antibody therapy options for blood cancer and decided to base Amphivena Therapeutics around that idea. Even today she continues to devote herself to researching and developing new drugs to treat some of the world’s most dangerous diseases.  Follow along with her career on Dr. Guenot’s Facebook.